Axon Enterprise vs Sichuan Tianwei Electronic: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Axon Enterprise Inc. (AXON)

Q3 202612 Jul – 16 Sep 2026

▲3▼1

Axon's record Q2 and AI growth offset by convertible bond dilution

Record Q2 revenue and raised guidance Axon reported record Q2 2026 revenue of $904 million, up 35% year over year, and raised full-year growth guidance to 32–34%. Bookings rose 41% to $15.1 billion, and annual recurring revenue climbed 39% to $1.6 billion, showing strong demand.
This is the core positive driver of the period, showing accelerating growth and demand.
AI product sales surge and new AI board member AI product sales surged over 700%, and Axon added a new AI-focused board member. This reinforces Axon's leadership in AI for public safety and supports future growth prospects.
Highlights the technology and talent drivers that boost investor confidence.
Renewed 10-year LAPD contract Axon renewed a 10-year contract with the Los Angeles Police Department, securing a major long-term customer. This provides revenue visibility and validates Axon's products with a key agency.
Shows continued demand from a major public safety agency, supporting future revenue.
Convertible bond sparks dilution and leverage concerns A $1 billion zero-coupon convertible bond due 2031 raised dilution and leverage worries, sending shares down about 10%. Adjusted EPS of $1.88 slightly missed estimates, and net income fell to $29 million from $36 million, with margin pressure.
This is the main negative force that pressured the stock during the period.

August 202612 Jul – 16 Sep 2026

▲3▼1

Axon's record Q2 and AI growth offset by convertible bond dilution

Record Q2 revenue and raised guidance Axon reported record Q2 2026 revenue of $904 million, up 35% year over year, and raised full-year growth guidance to 32–34%. Bookings rose 41% to $15.1 billion, and annual recurring revenue climbed 39% to $1.6 billion, showing strong demand.
This is the core positive driver of the period, showing accelerating growth and demand.
AI product sales surge and new AI board member AI product sales surged over 700%, and Axon added a new AI-focused board member. This reinforces Axon's leadership in AI for public safety and supports future growth prospects.
Highlights the technology and talent drivers that boost investor confidence.
Renewed 10-year LAPD contract Axon renewed a 10-year contract with the Los Angeles Police Department, securing a major long-term customer. This provides revenue visibility and validates Axon's products with a key agency.
Shows continued demand from a major public safety agency, supporting future revenue.
Convertible bond sparks dilution and leverage concerns A $1 billion zero-coupon convertible bond due 2031 raised dilution and leverage worries, sending shares down about 10%. Adjusted EPS of $1.88 slightly missed estimates, and net income fell to $29 million from $36 million, with margin pressure.
This is the main negative force that pressured the stock during the period.

Latest23 Jul – 16 Sep 2026

▲3▼1

Axon's growth stays strong, but a $1B convertible bond spooks investors

AI push and board expertise Axon added AI entrepreneur Eiso Kant to its board, bringing expertise in AI infrastructure. This supports its public safety tech, drone and counter-drone growth. For investors, it signals the company is investing in the technology that is driving its fastest-growing products.
Shows a new strategic move supporting Axon's AI-driven growth story.
Blowout revenue and raised outlook Axon's second-quarter revenue jumped 35% to $904 million, beating expectations, and management raised full-year growth guidance to 32-34%. Both hardware and software grew strongly. This confirms demand for Axon's products remains very strong, which is the main reason investors own the stock.
The core fundamental driver: strong demand and raised guidance.
Record growth streak and big contract win Axon posted its ninth straight quarter of at least 30% revenue growth, with AI product sales up over 700% year over year, and renewed a 10-year contract with the Los Angeles Police Department. These show durable demand and a sticky customer base, supporting the long-term growth story.
Evidence of sustained demand momentum and contract wins.
$1B convertible bond raises dilution worries Axon closed a $1 billion zero-coupon convertible bond due 2031, sending shares down about 10%. The bonds can convert into stock, potentially diluting existing shareholders, and add leverage to a company already carrying net debt. Investors worry about the cost of funding future acquisitions.
The main new negative force pressuring the stock this period.

12 Jul – 21 Aug 2026

▲3▼1

Axon's record Q2 and raised outlook drive growth story

Record Q2 revenue and raised full-year outlook Axon reported Q2 revenue of $904 million, up 35% year over year, and raised its 2026 revenue growth guidance to 32-34% from 30-32%. This shows strong demand for its products and boosts investor confidence in future growth.
This is the core new event that directly lifts Axon's growth prospects and stock price.
Strong bookings and recurring revenue Future contracted bookings jumped 41% to $15.1 billion, and annual recurring revenue rose 39% to $1.6 billion with net revenue retention at 126%. This means customers are committing to more Axon products and services, providing predictable future income.
It highlights the underlying demand strength that supports the raised outlook and long-term growth.
Q2 earnings miss and margin pressure Despite revenue growth, adjusted earnings per share of $1.88 missed the consensus estimate of $1.89, and net income fell to $29 million from $36 million a year earlier. This shows costs are rising and profitability is under pressure, which can weigh on the stock.
It provides the main counterweight to the positive revenue news and explains why the stock dropped after earnings.
New Taser product (Apollo) on track Axon is close to finalizing its Apollo cartridge, a new Taser designed to outperform a nine-millimeter bullet, with a target release by next winter. This innovation could open new markets and drive future sales.
It is a new product development that supports the long-term growth narrative beyond current results.

Q2 202619 Jun – 2 Jul 2026

▲3

Axon's AI and counter-drone boom, plus federal contract hopes, drive the stock

AI and software revenue surge Axon's AI product revenue jumped over 700% and software revenue rose 35%, pushing Q1 revenue up 34% to $807 million. Management raised full-year growth guidance to 30-32%. This shows the company's core business is growing much faster than expected, which supports a higher stock price.
This is the fundamental growth driver behind the stock's move and a new guidance raise.
Counter-drone platform Dedrone takes off Axon's Dedrone counter-drone business grew about 300% year-over-year and has already brought in more bookings than its purchase price. The 2026 World Cup is a near-term opportunity. This fast-growing new product line adds a fresh revenue stream and boosts investor excitement.
Dedrone's rapid growth is a new, concrete driver of future revenue and stock momentum.
Trump stake and ICE contract signal federal demand President Trump bought $1M-$5M of Axon stock in February, and ICE later sought a $220M Taser contract matching Axon's specs. While the contract isn't awarded and no wrongdoing is proven, the news suggests more federal business ahead, lifting the stock.
This is a major new catalyst that directly boosted the stock by 10% and points to potential federal contracts.
Political controversy and valuation risk Axon faces scrutiny over alleged involvement in a Scottsdale city council race, which could hurt its reputation with public agencies. Also, the stock trades at a very high price-to-earnings ratio near 100 and is still 30% below its peak, so any bad news could trigger sharp drops.
This is the main counterweight: reputational and valuation risks that could push the stock down despite strong growth.

June 202619 Jun – 2 Jul 2026

▲3

Axon's AI and counter-drone boom, plus federal contract hopes, drive the stock

AI and software revenue surge Axon's AI product revenue jumped over 700% and software revenue rose 35%, pushing Q1 revenue up 34% to $807 million. Management raised full-year growth guidance to 30-32%. This shows the company's core business is growing much faster than expected, which supports a higher stock price.
This is the fundamental growth driver behind the stock's move and a new guidance raise.
Counter-drone platform Dedrone takes off Axon's Dedrone counter-drone business grew about 300% year-over-year and has already brought in more bookings than its purchase price. The 2026 World Cup is a near-term opportunity. This fast-growing new product line adds a fresh revenue stream and boosts investor excitement.
Dedrone's rapid growth is a new, concrete driver of future revenue and stock momentum.
Trump stake and ICE contract signal federal demand President Trump bought $1M-$5M of Axon stock in February, and ICE later sought a $220M Taser contract matching Axon's specs. While the contract isn't awarded and no wrongdoing is proven, the news suggests more federal business ahead, lifting the stock.
This is a major new catalyst that directly boosted the stock by 10% and points to potential federal contracts.
Political controversy and valuation risk Axon faces scrutiny over alleged involvement in a Scottsdale city council race, which could hurt its reputation with public agencies. Also, the stock trades at a very high price-to-earnings ratio near 100 and is still 30% below its peak, so any bad news could trigger sharp drops.
This is the main counterweight: reputational and valuation risks that could push the stock down despite strong growth.

19 Jun – 2 Jul 2026

▲3

Axon's AI and counter-drone boom, plus federal contract hopes, drive the stock

AI and software revenue surge Axon's AI product revenue jumped over 700% and software revenue rose 35%, pushing Q1 revenue up 34% to $807 million. Management raised full-year growth guidance to 30-32%. This shows the company's core business is growing much faster than expected, which supports a higher stock price.
This is the fundamental growth driver behind the stock's move and a new guidance raise.
Counter-drone platform Dedrone takes off Axon's Dedrone counter-drone business grew about 300% year-over-year and has already brought in more bookings than its purchase price. The 2026 World Cup is a near-term opportunity. This fast-growing new product line adds a fresh revenue stream and boosts investor excitement.
Dedrone's rapid growth is a new, concrete driver of future revenue and stock momentum.
Trump stake and ICE contract signal federal demand President Trump bought $1M-$5M of Axon stock in February, and ICE later sought a $220M Taser contract matching Axon's specs. While the contract isn't awarded and no wrongdoing is proven, the news suggests more federal business ahead, lifting the stock.
This is a major new catalyst that directly boosted the stock by 10% and points to potential federal contracts.
Political controversy and valuation risk Axon faces scrutiny over alleged involvement in a Scottsdale city council race, which could hurt its reputation with public agencies. Also, the stock trades at a very high price-to-earnings ratio near 100 and is still 30% below its peak, so any bad news could trigger sharp drops.
This is the main counterweight: reputational and valuation risks that could push the stock down despite strong growth.

Sichuan Tianwei Electronic Co Ltd (688511.CG)

Q3 202630 Jul – 30 Sep 2026

▼3

Tianwei's core client business restricted, orders cancelled; acquisition terminated

Core client business restricted until May 2027, orders cancelled Tianwei's business with its main client (over 93% of revenue) is restricted until May 2027. Some orders worth 6.47 million yuan are cancelled, and 98.19 million yuan of signed orders can't be delivered on time. This threatens a delisting risk warning if revenue falls below 100 million yuan with losses.
This is the biggest new negative event, directly threatening revenue and listing status.
Acquisition of Xiuwei Technology terminated Tianwei planned to buy 60% of Xiuwei Technology for 90 million yuan to expand into military information equipment, but the deal was called off due to changed external conditions. The company says no harm to operations or strategy, but the expected growth boost is gone.
This removes a previously announced positive growth driver, leaving the company without that expansion.
First-half profit plunged 94% on military certificate delay Tianwei's first-half 2026 net profit fell 94.12% to 1.63 million yuan, and revenue dropped 64.85% to 29.53 million yuan. A military qualification certificate under review delayed deliveries and hurt revenue. This confirms weak financial performance.
The interim report confirms the earnings collapse first warned about in July, a key negative for the stock.

August 202630 Jul – 30 Sep 2026

▼3

Tianwei's core client business restricted, orders cancelled; acquisition terminated

Core client business restricted until May 2027, orders cancelled Tianwei's business with its main client (over 93% of revenue) is restricted until May 2027. Some orders worth 6.47 million yuan are cancelled, and 98.19 million yuan of signed orders can't be delivered on time. This threatens a delisting risk warning if revenue falls below 100 million yuan with losses.
This is the biggest new negative event, directly threatening revenue and listing status.
Acquisition of Xiuwei Technology terminated Tianwei planned to buy 60% of Xiuwei Technology for 90 million yuan to expand into military information equipment, but the deal was called off due to changed external conditions. The company says no harm to operations or strategy, but the expected growth boost is gone.
This removes a previously announced positive growth driver, leaving the company without that expansion.
First-half profit plunged 94% on military certificate delay Tianwei's first-half 2026 net profit fell 94.12% to 1.63 million yuan, and revenue dropped 64.85% to 29.53 million yuan. A military qualification certificate under review delayed deliveries and hurt revenue. This confirms weak financial performance.
The interim report confirms the earnings collapse first warned about in July, a key negative for the stock.

Latest30 Jul – 30 Sep 2026

▼3

Tianwei's core client business restricted, orders cancelled; acquisition terminated

Core client business restricted until May 2027, orders cancelled Tianwei's business with its main client (over 93% of revenue) is restricted until May 2027. Some orders worth 6.47 million yuan are cancelled, and 98.19 million yuan of signed orders can't be delivered on time. This threatens a delisting risk warning if revenue falls below 100 million yuan with losses.
This is the biggest new negative event, directly threatening revenue and listing status.
Acquisition of Xiuwei Technology terminated Tianwei planned to buy 60% of Xiuwei Technology for 90 million yuan to expand into military information equipment, but the deal was called off due to changed external conditions. The company says no harm to operations or strategy, but the expected growth boost is gone.
This removes a previously announced positive growth driver, leaving the company without that expansion.
First-half profit plunged 94% on military certificate delay Tianwei's first-half 2026 net profit fell 94.12% to 1.63 million yuan, and revenue dropped 64.85% to 29.53 million yuan. A military qualification certificate under review delayed deliveries and hurt revenue. This confirms weak financial performance.
The interim report confirms the earnings collapse first warned about in July, a key negative for the stock.